Enzymicals AG expands the online access to its products and services

Published: 13-Jun-2019

Enzymicals expands the online access to its products and services via Science Exchange and Science.com

Life sciences companies often turn to established marketplaces to assess and contact suppliers of research services.

In addition to the SAP Ariba system implemented since 2014 and distribution of catalogue products via abcr web shop, Enzymicals was recently designated as an approved supplier by two of the most trusted marketplaces in the life science industry.

Enzymicals AG expands the online access to its products and services

This allows scientists to find and order Enzymicals research and development services through pre-negotiated legal terms that mutually protect confidentiality and IP.

  • Companies:
  • Enzymicals
See more

You may also like

Research & Development

Experts discuss lyase for selective ring opening of di-substituted epoxides

Read more
Enzymicals scientists debate how to get one out of four: regio- and stereoselective ring opening of di-substituted epoxides catalysed by halohydrin dehalogenases

Trending Articles

  1. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
  2. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  3. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  5. Steritas and argenx join forces to advance steroid-sparing therapeutic development With the help of Steritas' STOX Suite, argenx aims to develop antibody-based therapeutics for immune diseases, potentially allowing patients to move away from chronic steroid usage

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Research & Development

Experts discuss lyase for selective ring opening of di-substituted epoxides

Enzymicals scientists debate how to get one out of four: regio- and stereoselective ring opening of di-substituted epoxides catalysed by halohydrin dehalogenases
Ingredients

New enantioselective desymmetrisation strategy uses recombinant pig liver esterases

Enzymicals has established a new compound from the development of an efficient biocatalytic sequential multistep one-pot reaction
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Biocatalytic access to a novel class of Mannich catalysts

Dr Rainer Wardenga, Chief Scientific Officer at Enzymicals AG, discusses the synthesis of novel diastereomers of 5-benzyl-Ca-methyl-b-proline by the stereoselective hydrolysis of branched malonate diesters
Manufacturing

Synthetic approaches with Enzymicals recombinant pig liver esterases

Enzymicals provides biocatalytic access to a novel class of Mannich catalysts and a new bicyclic carboxylic acid ester
Ingredients

Enzymicals biocatalysts for straightforward synthesis of phosphorylated metabolites

Enzymicals AG provides a selection of highly active, long-term stable, regio- and enantioselective phosphotransferases/kinases to enable or simplify the production of enantiopure key metabolites and intermediates.
Ingredients

Enantiopure Rimantadine: robust and easy by kinetic resolution with Amine Transaminase

Enzymicals has developed a new simple and robust way to manufacture enantiopure Rimantadine
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Successful application of enzyme cascades in API synthesis

Rainer Wardenga and Torsten Sehl illustrate how amine-transaminases can be used in a novel two-step biocatalytic route for production of all four stereoisomers of nor(pseudo)ephedrine from inexpensive, achiral starting materials
Subscribe now